An overhaul of administrative mechanism is required the in drug approval system of the country. Elaborate (200 Words)
Refer - Financial Express
Enrich the answer from other sources, if the question demands.
IAS Parliament 2 years
KEY POINTS
· The Central Bureau of Investigation’s (CBI) decision to arrest the Joint Drugs Controller on charges of receiving a bribe to waive the phase three clinical trial of an insulin injection again brings into focus the poor state of the Indian drug approval mechanism.
· Strong accusations have been made against a high-ranking regulatory official and a reputed company like Biocon Biologics, a subsidiary of Biocon.
· CBI claims it has got enough evidence for the arrests under IPC sections of criminal conspiracy and corruption for bypassing regulatory processes.
· The example of Ranbaxy is one of India’s biggest drug manufacturers , Ranbaxy pleaded guilty to felony charges and paid a $500 million fine.
· Citing a Parliamentary committee report on the functioning of the CDSCO, which highlighted serious lapses in India’s drug approval standards, the petition highlighted how approvals had reached a slippery slope.
· High variety gives more flexibility to produce goods and services to match a customer’s requirements. Variety and volume correlate the higher the variety, the lower the volume of products or services.
· The fact also is that India’s drug regulatory bodies, both at the central and state level, are grossly understaffed and underfunded, and have faced charges of either corruption or lacking the expertise to oversee a sophisticated industry.
K. V. A 2 years
Kindly review
IAS Parliament 2 years
Good attempt. Keep Writing.
